Future studies incorporating later-stage AKI datasets and experimental validation at the cellular and molecular levels are needed to confirm whether the co-expression of Ccl6 and Ccr2 directly contributes to renal fibrosis progression. This evidence concerns the gene CCR2 and acute kidney injury.